A Phase I Open-Label Study of Picoplatin in Combination With 5-Fluorouracil and Leucovorin as Initial Therapy in Subjects With Metastatic Colorectal Cancer.

Trial Profile

A Phase I Open-Label Study of Picoplatin in Combination With 5-Fluorouracil and Leucovorin as Initial Therapy in Subjects With Metastatic Colorectal Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Apr 2009

At a glance

  • Drugs Picoplatin (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Cancer metastases; Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Apr 2009 Final tolerability and pharmacokinetic data presented at the 100th Annual Meeting of the American Association for Cancer Research (AACR-2009).
    • 21 Apr 2009 Status changed from active, no longer recruiting to completed.
    • 06 May 2008 Interim results will be reported at ASCO 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top